• Je něco špatně v tomto záznamu ?

Submicron immunoglobulin particles exhibit FcγRII-dependent toxicity linked to autophagy in TNFα-stimulated endothelial cells

WC. Hollis, S. Farooq, MR. Khoshi, M. Patel, E. Karnaukhova, N. Eller, K. Holada, DE. Scott, J. Simak

. 2024 ; 81 (1) : 376. [pub] 20240830

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24019235

Grantová podpora
U.S. Food and Drug Administration U.S. Food and Drug Administration
U.S. Food and Drug Administration U.S. Food and Drug Administration

In intravenous immunoglobulins (IVIG), and some other immunoglobulin products, protein particles have been implicated in adverse events. Role and mechanisms of immunoglobulin particles in vascular adverse effects of blood components and manufactured biologics have not been elucidated. We have developed a model of spherical silica microparticles (SiMPs) of distinct sizes 200-2000 nm coated with different IVIG- or albumin (HSA)-coronas and investigated their effects on cultured human umbilical vein endothelial cells (HUVEC). IVIG products (1-20 mg/mL), bare SiMPs or SiMPs with IVIG-corona, did not display significant toxicity to unstimulated HUVEC. In contrast, in TNFα-stimulated HUVEC, IVIG-SiMPs induced decrease of HUVEC viability compared to HSA-SiMPs, while no toxicity of soluble IVIG was observed. 200 nm IVIG-SiMPs after 24 h treatment further increased ICAM1 (intercellular adhesion molecule 1) and tissue factor surface expression, apoptosis, mammalian target of rapamacin (mTOR)-dependent activation of autophagy, and release of extracellular vesicles, positive for mitophagy markers. Toxic effects of IVIG-SiMPs were most prominent for 200 nm SiMPs and decreased with larger SiMP size. Using blocking antibodies, toxicity of IVIG-SiMPs was found dependent on FcγRII receptor expression on HUVEC, which increased after TNFα-stimulation. Similar results were observed with different IVIG products and research grade IgG preparations. In conclusion, submicron particles with immunoglobulin corona induced size-dependent toxicity in TNFα-stimulated HUVEC via FcγRII receptors, associated with apoptosis and mTOR-dependent activation of autophagy. Testing of IVIG toxicity in endothelial cells prestimulated with proinflammatory cytokines is relevant to clinical conditions. Our results warrant further studies on endothelial toxicity of sub-visible immunoglobulin particles.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24019235
003      
CZ-PrNML
005      
20241024111404.0
007      
ta
008      
241015s2024 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00018-024-05342-9 $2 doi
035    __
$a (PubMed)39212707
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Hollis, Wanida C $u Center for Biologics Evaluation and Research, FDA, Silver Spring, MD, USA
245    10
$a Submicron immunoglobulin particles exhibit FcγRII-dependent toxicity linked to autophagy in TNFα-stimulated endothelial cells / $c WC. Hollis, S. Farooq, MR. Khoshi, M. Patel, E. Karnaukhova, N. Eller, K. Holada, DE. Scott, J. Simak
520    9_
$a In intravenous immunoglobulins (IVIG), and some other immunoglobulin products, protein particles have been implicated in adverse events. Role and mechanisms of immunoglobulin particles in vascular adverse effects of blood components and manufactured biologics have not been elucidated. We have developed a model of spherical silica microparticles (SiMPs) of distinct sizes 200-2000 nm coated with different IVIG- or albumin (HSA)-coronas and investigated their effects on cultured human umbilical vein endothelial cells (HUVEC). IVIG products (1-20 mg/mL), bare SiMPs or SiMPs with IVIG-corona, did not display significant toxicity to unstimulated HUVEC. In contrast, in TNFα-stimulated HUVEC, IVIG-SiMPs induced decrease of HUVEC viability compared to HSA-SiMPs, while no toxicity of soluble IVIG was observed. 200 nm IVIG-SiMPs after 24 h treatment further increased ICAM1 (intercellular adhesion molecule 1) and tissue factor surface expression, apoptosis, mammalian target of rapamacin (mTOR)-dependent activation of autophagy, and release of extracellular vesicles, positive for mitophagy markers. Toxic effects of IVIG-SiMPs were most prominent for 200 nm SiMPs and decreased with larger SiMP size. Using blocking antibodies, toxicity of IVIG-SiMPs was found dependent on FcγRII receptor expression on HUVEC, which increased after TNFα-stimulation. Similar results were observed with different IVIG products and research grade IgG preparations. In conclusion, submicron particles with immunoglobulin corona induced size-dependent toxicity in TNFα-stimulated HUVEC via FcγRII receptors, associated with apoptosis and mTOR-dependent activation of autophagy. Testing of IVIG toxicity in endothelial cells prestimulated with proinflammatory cytokines is relevant to clinical conditions. Our results warrant further studies on endothelial toxicity of sub-visible immunoglobulin particles.
650    _2
$a lidé $7 D006801
650    12
$a TNF-alfa $x metabolismus $7 D014409
650    12
$a endoteliální buňky pupečníkové žíly (lidské) $x účinky léků $x metabolismus $7 D061307
650    12
$a autofagie $x účinky léků $7 D001343
650    12
$a receptory IgG $x metabolismus $7 D017452
650    12
$a intravenózní imunoglobuliny $7 D016756
650    _2
$a velikost částic $7 D010316
650    _2
$a oxid křemičitý $x chemie $x toxicita $7 D012822
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a mezibuněčná adhezivní molekula-1 $x metabolismus $7 D018799
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a proteinová korona $x metabolismus $7 D000066970
650    _2
$a TOR serin-threoninkinasy $x metabolismus $7 D058570
655    _2
$a časopisecké články $7 D016428
700    1_
$a Farooq, Sehrish $u Center for Biologics Evaluation and Research, FDA, Silver Spring, MD, USA
700    1_
$a Khoshi, M Reza $u Center for Biologics Evaluation and Research, FDA, Silver Spring, MD, USA
700    1_
$a Patel, Mehulkumar $u Center for Biologics Evaluation and Research, FDA, Silver Spring, MD, USA $u Center for Devices and Radiological Health, FDA, Silver Spring, MD, USA
700    1_
$a Karnaukhova, Elena $u Center for Biologics Evaluation and Research, FDA, Silver Spring, MD, USA
700    1_
$a Eller, Nancy $u Center for Biologics Evaluation and Research, FDA, Silver Spring, MD, USA
700    1_
$a Holada, Karel $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Scott, Dorothy E $u Center for Biologics Evaluation and Research, FDA, Silver Spring, MD, USA
700    1_
$a Simak, Jan $u Center for Biologics Evaluation and Research, FDA, Silver Spring, MD, USA. jan.simak@fda.hhs.gov $u Laboratory of Cellular Hematology, Division of Blood Components and Devices, Center for Biologics Evaluation and Research, Food and Drug Administration, OBRR, 10903 New Hampshire Avenue, WO Bldg. 52/72, Rm. 4210, Silver Spring, MD, USA. jan.simak@fda.hhs.gov $1 https://orcid.org/0000000189107362
773    0_
$w MED00001078 $t Cellular and molecular life sciences : CMLS $x 1420-9071 $g Roč. 81, č. 1 (2024), s. 376
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39212707 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024111358 $b ABA008
999    __
$a ok $b bmc $g 2201845 $s 1231208
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 81 $c 1 $d 376 $e 20240830 $i 1420-9071 $m Cellular and molecular life sciences : CMLS $n Cell Mol Life Sci $x MED00001078
GRA    __
$a U.S. Food and Drug Administration $p U.S. Food and Drug Administration
GRA    __
$a U.S. Food and Drug Administration $p U.S. Food and Drug Administration
LZP    __
$a Pubmed-20241015

Najít záznam

Citační ukazatele

Možnosti archivace